Previous 10 | Next 10 |
Today, we revisit a promising small cap biopharma concern named Pieris Pharmaceuticals for the first time in just over two years. The company has made some progress advancing its pipeline and recently signed a potentially significant collaboration deal with Genentech. A full inves...
BOSTON, MA / ACCESSWIRE / October 26, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer and other indications, today annou...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips I don’t get my investment advice from Robert Kiyosaki, the famous (or infamous) author of the Rich Dad, Poor Dad series of books. However, I can understand his latest cause for concern regarding the supposed global...
Shares of Pieris Pharmaceuticals Inc. (NASDAQ:PIRS) traded at a new 52-week high today of $6.15. Approximately 29.7 million shares have changed hands today, as compared to an average 30-day volume of 1.6 million shares. Over the past year, Pieris Pharmaceuticals Inc. has traded in a rang...
Gainers: ZIVO Bioscience (NASDAQ:ZIVO) +68%, Pieris Pharmaceuticals (NASDAQ:PIRS) +11%, Molecular Templates (NASDAQ:MTEM) +11%, Paratek Pharmaceuticals (NASDAQ:PRTK) +9%, Capricor Therapeutics CAPR +4%. Losers: Kintara Therapeutics KTRA -19%, Oncon...
Are These Penny Stocks Worth Watching This Week? With a three-day weekend at hand, many investors are looking for the best penny stocks to buy. And, this weekend also signals the first full week of September, which could bring about renewed bullish sentiment into the market. While a...
These Penny Stocks May Turn Heads Next Month A great thing about penny stocks and the market, in general, is that there isn’t one right or wrong way to research. Where some traders look at fundamentals and corporate growth, others seek out technical trends and market momentum...
In 2019, tiny Axsome Therapeutics (NASDAQ: AXSM) emerged from micro-cap obscurity to become the best-performing stock in the market, rising by an amazing 3,600% in a year. In 2020, another tiny biotech, Novavax (NASDAQ: NVAX) , came out of nowhere to stomp the stock mark...
BOSTON, MA / ACCESSWIRE / August 24, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for respiratory diseases, cancer, and other indications, announ...
Pieris Pharmaceuticals (NASDAQ:PIRS): Q2 GAAP EPS of -$0.25 beats by $0.02. Revenue of $3.29M (-70.8% Y/Y) beats by $1.21M. Cash and cash equivalents totaled $119.1M for the quarter ended June 30, 2021, compared to a cash and cash equivalents balance of $70.4M for the year ended December 31, ...
News, Short Squeeze, Breakout and More Instantly...
Pieris Pharmaceuticals Inc. Company Name:
PIRS Stock Symbol:
NASDAQ Market:
Pieris Pharmaceuticals Inc. Website:
2024-07-27 03:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 75.8% to $0.0457 on volume of 1,196,767,473 shares NVIDIA Corporation (NVDA) fell 6.8% to $114.25 on volume of 316,196,296 shares Sangamo Therapeutics Inc. (SGMO) rose 39.5% to $0.56 on volume of 261...
A look at the top 10 most actives in the United States Sangamo Therapeutics Inc. (SGMO) rose 50.7% to $0.604699 on volume of 90,844,210 shares Selina Hospitality PLC (SLNA) rose 7.7% to $0.028 on volume of 57,431,570 shares NuZee Inc. (NUZE) rose 260.1% to $3.7094 on volume of 53,639,595 ...